Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect?

This publication has 57 references indexed in Scilit:

• Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients
  Diabetes Research and Clinical Practice, 2007
• Blockade of the Renin-Angiotensin System Increases Plasma Adiponectin Levels in Type-2 Diabetic Patients with Proteinuria
  Nephron Clinical Practice, 2005
• Contrasting Metabolic Effects of Antihypertensive Agents
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
  Published by Rockefeller University Press ,2003
• Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance
  Diabetes, Obesity and Metabolism, 2003
• The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?
  The International Journal of Biochemistry & Cell Biology, 2003
• Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
  Hypertension, 2002
• The Role of the Angiotensin System in Cardiac Glucose Homeostasis
  Drugs, 2002
• Mechanism of differential effects of antihypertensive agents on serum lipids.
  Current Hypertension Reports, 2000
• The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor
  Immunopharmacology, 1999